obagi-c c-rx system normal-oily skin intervention

Generic: hydroquinone, homosalate, octisalate, zinc oxide

Labeler: obagi cosmeceuticals llc
NDC Directory HUMAN OTC DRUG UNAPPROVED DRUG OTHER Inactive Finished

Drug Facts

Product Profile

Brand Name obagi-c c-rx system normal-oily skin intervention
Generic Name hydroquinone, homosalate, octisalate, zinc oxide
Labeler obagi cosmeceuticals llc
Dosage Form KIT
Manufacturer
Obagi Cosmeceuticals LLC

Identifiers & Regulatory

Product NDC 62032-915
Product ID 62032-915_d5a6773d-ca09-4b9a-8cbb-4611d29fb7a7
Product Type HUMAN OTC DRUG
Marketing Category UNAPPROVED DRUG OTHER
Listing Expiration 2026-12-31
Marketing Start 2019-12-02

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 62032915
Hyphenated Format 62032-915

Supplemental Identifiers

RxCUI
197795

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name obagi-c c-rx system normal-oily skin intervention (source: ndc)
Generic Name hydroquinone, homosalate, octisalate, zinc oxide (source: ndc)

Resolved Composition

Strengths
  • 10 %
  • 5 %
  • 16.5 %
source: label
Packaging
  • 1 KIT in 1 KIT (62032-915-01) * 177 mL in 1 BOTTLE, PLASTIC * 198 mL in 1 BOTTLE, PLASTIC * 30 mL in 1 BOTTLE, GLASS (62032-122-10) * 1 TUBE in 1 CARTON (62032-140-09) / 85 g in 1 TUBE * 57 g in 1 BOTTLE, PLASTIC (62032-105-36)
source: ndc

Packages (1)

62032-915-01 1 KIT in 1 KIT (62032-915-01) * 177 mL in 1 BOTTLE, PLASTIC * 198 mL in 1 BOTTLE, PLASTIC * 30 mL in 1 BOTTLE, GLASS (62032-122-10) * 1 TUBE in 1 CARTON (62032-140-09) / 85 g in 1 TUBE * 57 g in 1 BOTTLE, PLASTIC (62032-105-36)

Ingredients (0)

No ingredient records.

Linked Drug Pages (1)

Obagi-C C-Rx System Normal-Oily Skin Intervention ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"spl_id": "d5a6773d-ca09-4b9a-8cbb-4611d29fb7a7", "openfda": {"rxcui": ["197795"], "spl_set_id": ["e19b824f-4438-48c8-af4c-29be197f9cdc"], "manufacturer_name": ["Obagi Cosmeceuticals LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 KIT in 1 KIT (62032-915-01)  *  177 mL in 1 BOTTLE, PLASTIC *  198 mL in 1 BOTTLE, PLASTIC *  30 mL in 1 BOTTLE, GLASS (62032-122-10)  *  1 TUBE in 1 CARTON (62032-140-09)  / 85 g in 1 TUBE *  57 g in 1 BOTTLE, PLASTIC (62032-105-36)", "package_ndc": "62032-915-01", "marketing_start_date": "20210625"}], "brand_name": "Obagi-C C-Rx System Normal-Oily Skin Intervention", "product_id": "62032-915_d5a6773d-ca09-4b9a-8cbb-4611d29fb7a7", "dosage_form": "KIT", "product_ndc": "62032-915", "generic_name": "HYDROQUINONE, HOMOSALATE, OCTISALATE, ZINC OXIDE", "labeler_name": "Obagi Cosmeceuticals LLC", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Obagi-C C-Rx System Normal-Oily Skin Intervention", "marketing_category": "UNAPPROVED DRUG OTHER", "marketing_start_date": "20191202", "listing_expiration_date": "20261231"}